{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:45:40Z","timestamp":1790484340874,"version":"4.1.0"},"publisher-location":"Cham","reference-count":219,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319582887","type":"print"},{"value":"9783319582900","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/164_2016_84","type":"book-chapter","created":{"date-parts":[[2016,10,25]],"date-time":"2016-10-25T04:09:44Z","timestamp":1477368584000},"page":"57-93","source":"Crossref","is-referenced-by-count":46,"title":["Ocular Drug Delivery"],"prefix":"10.1007","author":[{"given":"Burcin","family":"Yavuz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uday B.","family":"Kompella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,26]]},"reference":[{"issue":"1","key":"84_CR1","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3109\/10837450903479988","volume":"16","author":"G Abdelbary","year":"2011","unstructured":"Abdelbary G (2011) Ocular ciprofloxacin hydrochloride mucoadhesive chitosan-coated liposomes. Pharm Dev Technol 16(1):44\u201356","journal-title":"Pharm Dev Technol"},{"key":"84_CR2","unstructured":"Aciont. Available from: http:\/\/www.aciont.com\/technologies\/visulex"},{"issue":"4","key":"84_CR3","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1517\/17425247.2012.665367","volume":"9","author":"AK Agrawal","year":"2012","unstructured":"Agrawal AK, Das M, Jain S (2012) In situ gel systems as \u2018smart\u2019 carriers for sustained ocular drug delivery. Expert Opin Drug Deliv 9(4):383\u2013402","journal-title":"Expert Opin Drug Deliv"},{"issue":"4","key":"84_CR4","first-page":"584","volume":"26","author":"I Ahmed","year":"1985","unstructured":"Ahmed I, Patton TF (1985) Importance of the noncorneal absorption route in topical ophthalmic drug delivery. Invest Ophthalmol Vis Sci 26(4):584\u2013587","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"84_CR5","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jconrel.2011.01.010","volume":"151","author":"P Aksungur","year":"2011","unstructured":"Aksungur P, Demirbilek M, Denkbas EB, Vandervoort J, Ludwig A, Unlu N (2011) Development and characterization of cyclosporine A loaded nanoparticles for ocular drug delivery: cellular toxicity, uptake, and kinetic studies. J Control Release 151(3):286\u2013294","journal-title":"J Control Release"},{"issue":"12","key":"84_CR6","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1211\/jpp.57.12.0005","volume":"57","author":"AC Amrite","year":"2005","unstructured":"Amrite AC, Kompella UB (2005) Size-dependent disposition of nanoparticles and microparticles following subconjunctival administration. J Pharm Pharmacol 57(12):1555\u20131563","journal-title":"J Pharm Pharmacol"},{"key":"84_CR7","first-page":"150","volume":"14","author":"AC Amrite","year":"2008","unstructured":"Amrite AC, Edelhauser HF, Singh SR, Kompella UB (2008) Effect of circulation on the disposition and ocular tissue distribution of 20 nm nanoparticles after periocular administration. Mol Vis 14:150\u2013160","journal-title":"Mol Vis"},{"issue":"8","key":"84_CR8","volume":"9","author":"M Ang","year":"2014","unstructured":"Ang M (2014) Evaluation of a prednisolone acetate-loaded subconjunctival implant for the treatment of recurrent uveitis in a rabbit model. PLoS One 9(8), e97555","journal-title":"PLoS One"},{"issue":"6","key":"84_CR9","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2220\/biomedres.28.331","volume":"28","author":"Y Arakawa","year":"2007","unstructured":"Arakawa Y, Hashida N, Ohguro N, Yamazaki N, Onda M, Matsumoto S et al (2007) Eye-concentrated distribution of dexamethasone carried by sugar-chain modified liposome in experimental autoimmune uveoretinitis mice. Biomed Res 28(6):331\u2013334","journal-title":"Biomed Res"},{"issue":"5","key":"84_CR10","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1023\/A:1011060705599","volume":"18","author":"JV Aukunuru","year":"2001","unstructured":"Aukunuru JV, Sunkara G, Bandi N, Thoreson WB, Kompella UB (2001) Expression of multidrug resistance-associated protein (MRP) in human retinal pigment epithelial cells and its interaction with BAPSG, a novel aldose reductase inhibitor. Pharm Res 18(5):565\u2013572","journal-title":"Pharm Res"},{"issue":"8","key":"84_CR11","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1007\/s12272-001-1266-6","volume":"31","author":"AA Badawi","year":"2008","unstructured":"Badawi AA, El-Laithy HM, El Qidra RK, El Mofty H, El dally M (2008) Chitosan based nanocarriers for indomethacin ocular delivery. Arch Pharm Res 31(8):1040\u20131049","journal-title":"Arch Pharm Res"},{"issue":"5","key":"84_CR12","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1517\/17425247.5.5.567","volume":"5","author":"J Barar","year":"2008","unstructured":"Barar J, Javadzadeh AR, Omidi Y (2008) Ocular novel drug delivery: impacts of membranes and barriers. Expert Opin Drug Deliv 5(5):567\u2013581","journal-title":"Expert Opin Drug Deliv"},{"issue":"1","key":"84_CR13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0939-6411(03)00036-5","volume":"56","author":"L Baydoun","year":"2003","unstructured":"Baydoun L, Muller-Goymann CC (2003) Influence of n-octenylsuccinate starch on in vitro permeation of sodium diclofenac across excised porcine cornea in comparison to Voltaren ophtha. Eur J Pharm Biopharm 56(1):73\u201379","journal-title":"Eur J Pharm Biopharm"},{"issue":"4","key":"84_CR14","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1208\/s12249-011-9675-1","volume":"12","author":"P Bhagav","year":"2011","unstructured":"Bhagav P, Upadhyay H, Chandran S (2011) Brimonidine tartrate-eudragit long-acting nanoparticles: formulation, optimization, in vitro and in vivo evaluation. AAPS PharmSciTech 12(4):1087\u20131101","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"84_CR15","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1111\/aos.12235","volume":"92","author":"G Bikbova","year":"2014","unstructured":"Bikbova G, Bikbov M (2014) Transepithelial corneal collagen cross-linking by iontophoresis of riboflavin. Acta Ophthalmol 92(1):e30\u2013e34","journal-title":"Acta Ophthalmol"},{"issue":"9","key":"84_CR16","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.ophtha.2014.03.016","volume":"121","author":"F Bock","year":"2014","unstructured":"Bock F, Matthaei M, Reinhard T, Bohringer D, Christoph J, Ganslandt T et al (2014) High-dose subconjunctival cyclosporine A implants do not affect corneal neovascularization after high-risk keratoplasty. Ophthalmology 121(9):1677\u20131682","journal-title":"Ophthalmology"},{"issue":"11","key":"84_CR17","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.addr.2006.07.026","volume":"58","author":"JL Bourges","year":"2006","unstructured":"Bourges JL, Bloquel C, Thomas A, Froussart F, Bochot A, Azan F et al (2006) Intraocular implants for extended drug delivery: therapeutic applications. Adv Drug Deliv Rev 58(11):1182\u20131202","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"84_CR18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3109\/01676830.2011.648802","volume":"31","author":"R Bourkiza","year":"2012","unstructured":"Bourkiza R, Lee V (2012) A review of the complications of lacrimal occlusion with punctal and canalicular plugs. Orbit 31(2):86\u201393","journal-title":"Orbit"},{"issue":"2","key":"84_CR19","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaapos.2013.11.014","volume":"18","author":"ML Bratton","year":"2014","unstructured":"Bratton ML, He YG, Weakley DR (2014) Dexamethasone intravitreal implant (Ozurdex) for the treatment of pediatric uveitis. J AAPOS 18(2):110\u2013113","journal-title":"J AAPOS"},{"issue":"11","key":"84_CR20","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.2042-7158.1996.tb03911.x","volume":"48","author":"P Calvo","year":"1996","unstructured":"Calvo P, Alonso MJ, Vila-Jato JL, Robinson JR (1996) Improved ocular bioavailability of indomethacin by novel ocular drug carriers. J Pharm Pharmacol 48(11):1147\u20131152","journal-title":"J Pharm Pharmacol"},{"key":"84_CR21","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jconrel.2006.05.003","volume":"113","author":"AL Carmen","year":"2006","unstructured":"Carmen AL, Fernando Y, Rafael BI, Angel C (2006) Imprinted soft contact lenses as norfloxacin delivery systems. J Control Release 113:236\u2013424","journal-title":"J Control Release"},{"issue":"2","key":"84_CR22","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1089\/jop.2012.0193","volume":"29","author":"W Chaiyasan","year":"2013","unstructured":"Chaiyasan W, Srinivas SP, Tiyaboonchai W (2013) Mucoadhesive chitosan-dextran sulfate nanoparticles for sustained drug delivery to the ocular surface. J Ocul Pharmacol Ther 29(2):200\u2013207","journal-title":"J Ocul Pharmacol Ther"},{"issue":"3","key":"84_CR23","first-page":"487","volume":"28","author":"SC Chang","year":"1987","unstructured":"Chang SC, Bundgaard H, Buur A, Lee VH (1987) Improved corneal penetration of timolol by prodrugs as a means to reduce systemic drug load. Invest Ophthalmol Vis Sci 28(3):487\u2013491","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"84_CR24","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.exer.2015.10.009","volume":"145","author":"JE Chastain","year":"2016","unstructured":"Chastain JE, Sanders ME, Curtis MA, Chemuturi NV, Gadd ME, Kapin MA et al (2016) Distribution of topical ocular nepafenac and its active metabolite amfenac to the posterior segment of the eye. Exp Eye Res 145:58\u201367","journal-title":"Exp Eye Res"},{"key":"84_CR25","doi-asserted-by":"crossref","unstructured":"Chauhan A (2015) Ocular drug delivery role of contact lenses. Allied Ophthal Sci 26(2):131\u2013135","DOI":"10.7869\/djo.154"},{"issue":"4","key":"84_CR26","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1089\/jop.2011.0162","volume":"28","author":"SP Chee","year":"2012","unstructured":"Chee SP (2012) Moxifloxacin punctum plug for sustained drug delivery. J Ocul Pharmacol Ther 28(4):340\u2013349","journal-title":"J Ocul Pharmacol Ther"},{"issue":"10","key":"84_CR27","doi-asserted-by":"crossref","first-page":"4513","DOI":"10.1167\/iovs.06-0404","volume":"47","author":"NP Cheruvu","year":"2006","unstructured":"Cheruvu NP, Kompella UB (2006) Bovine and porcine transscleral solute transport: influence of lipophilicity and the Choroid-Bruch\u2019s layer. Invest Ophthalmol Vis Sci 47(10):4513\u20134522","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"84_CR28","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1167\/iovs.07-0214","volume":"49","author":"NP Cheruvu","year":"2008","unstructured":"Cheruvu NP, Amrite AC, Kompella UB (2008) Effect of eye pigmentation on transscleral drug delivery. Invest Ophthalmol Vis Sci 49(1):333\u2013341","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"84_CR29","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1021\/js950373b","volume":"86","author":"DS Chien","year":"1997","unstructured":"Chien DS, Tang-Liu DD, Woodward DF (1997) Ocular penetration and bioconversion of prostaglandin F2alpha prodrugs in rabbit cornea and conjunctiva. J Pharm Sci 86(10):1180\u20131186","journal-title":"J Pharm Sci"},{"issue":"1\u20132","key":"84_CR30","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijpharm.2009.12.046","volume":"388","author":"P Chopra","year":"2010","unstructured":"Chopra P, Hao J, Li SK (2010) Iontophoretic transport of charged macromolecules across human sclera. Int J Pharm 388(1\u20132):107\u2013113","journal-title":"Int J Pharm"},{"issue":"3\u20134","key":"84_CR31","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.drudis.2007.12.005","volume":"13","author":"JG Christie","year":"2008","unstructured":"Christie JG, Kompella UB (2008) Ophthalmic light sensitive nanocarrier systems. Drug Discov Today 13(3\u20134):124\u2013134","journal-title":"Drug Discov Today"},{"issue":"1","key":"84_CR32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1089\/108076804772745482","volume":"20","author":"C Civiale","year":"2004","unstructured":"Civiale C, Bucaria F, Piazza S, Peri O, Miano F, Enea V (2004) Ocular permeability screening of dexamethasone esters through combined cellular and tissue systems. J Ocul Pharmacol Ther 20(1):75\u201384","journal-title":"J Ocul Pharmacol Ther"},{"issue":"1\u20132","key":"84_CR33","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijpharm.2009.05.028","volume":"378","author":"C Civiale","year":"2009","unstructured":"Civiale C, Licciardi M, Cavallaro G, Giammona G, Mazzone MG (2009) Polyhydroxyethylaspartamide-based micelles for ocular drug delivery. Int J Pharm 378(1\u20132):177\u2013186","journal-title":"Int J Pharm"},{"issue":"1","key":"84_CR34","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ophtha.2011.07.006","volume":"119","author":"AE Cohen","year":"2012","unstructured":"Cohen AE, Assang C, Patane MA, From S, Korenfeld M (2012) Avion study investigators. Evaluation of dexamethasone phosphate delivered by ocular iontophoresis for treating noninfectious anterior uveitis. Ophthalmology 119(1):66\u201373","journal-title":"Ophthalmology"},{"issue":"5","key":"84_CR35","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/gt.2012.56","volume":"20","author":"L Contreras-Ruiz","year":"2013","unstructured":"Contreras-Ruiz L, Zorzi GK, Hileeto D, Lopez-Garcia A, Calonge M, Seijo B et al (2013) A nanomedicine to treat ocular surface inflammation: performance on an experimental dry eye murine model. Gene Ther 20(5):467\u2013477","journal-title":"Gene Ther"},{"issue":"6","key":"84_CR36","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1089\/108076802321021108","volume":"18","author":"LP Cruysberg","year":"2002","unstructured":"Cruysberg LP, Nuijts RM, Geroski DH, Koole LH, Hendrikse F, Edelhauser HF (2002) In vitro human scleral permeability of fluorescein, dexamethasone-fluorescein, methotrexate-fluorescein and rhodamine 6G and the use of a coated coil as a new drug delivery system. J Ocul Pharmacol Ther 18(6):559\u2013569","journal-title":"J Ocul Pharmacol Ther"},{"issue":"7","key":"84_CR37","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1046\/j.1440-1681.2000.03288.x","volume":"27","author":"NM Davies","year":"2000","unstructured":"Davies NM (2000) Biopharmaceutical considerations in topical ocular drug delivery. Clin Exp Pharmacol Physiol 27(7):558\u2013562","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"68\u201369","key":"84_CR38","first-page":"569","volume":"9","author":"JB Davies","year":"2003","unstructured":"Davies JB, Ciavatta VT, Boatright JH, Nickerson JM (2003) Delivery of several forms of DNA, DNA-RNA hybrids, and dyes across human sclera by electrical fields. Mol Vis 9(68\u201369):569\u2013578","journal-title":"Mol Vis"},{"issue":"8","key":"84_CR39","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/smll.201303433","volume":"10","author":"BM Davis","year":"2014","unstructured":"Davis BM, Normando EM, Guo L, Turner LA, Nizari S, O\u2019Shea P et al (2014) Topical delivery of Avastin to the posterior segment of the eye in vivo using annexin A5-associated liposomes. Small 10(8):1575\u20131584","journal-title":"Small"},{"issue":"1\u20132","key":"84_CR40","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0378-5173(01)00760-8","volume":"224","author":"AM Campos De","year":"2001","unstructured":"De Campos AM, Sanchez A, Alonso MJ (2001) Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A. Int J Pharm 224(1\u20132):159\u2013168","journal-title":"Int J Pharm"},{"issue":"11","key":"84_CR41","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1097\/ICO.0b013e31823f789e","volume":"31","author":"CS Paiva de","year":"2012","unstructured":"de Paiva CS, Schwartz CE, Gjorstrup P, Pflugfelder SC (2012) Resolvin E1 (RX-10001) reduces corneal epithelial barrier disruption and protects against goblet cell loss in a murine model of dry eye. Cornea 31(11):1299\u20131303","journal-title":"Cornea"},{"issue":"1","key":"84_CR42","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1517\/14712598.3.1.23","volume":"3","author":"S Dey","year":"2003","unstructured":"Dey S, Anand BS, Patel J, Mitra AK (2003) Transporters\/receptors in the anterior chamber: pathways to explore ocular drug delivery strategies. Expert Opin Biol Ther 3(1):23\u201344","journal-title":"Expert Opin Biol Ther"},{"issue":"2","key":"84_CR43","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ijpharm.2011.01.004","volume":"416","author":"C Tommaso Di","year":"2011","unstructured":"Di Tommaso C, Torriglia A, Furrer P, Behar-Cohen F, Gurny R, Moller M (2011) Ocular biocompatibility of novel cyclosporin A formulations based on methoxy poly(ethylene glycol)-hexylsubstituted poly(lactide) micelle carriers. Int J Pharm 416(2):515\u2013524","journal-title":"Int J Pharm"},{"key":"84_CR44","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejpb.2015.01.018","volume":"91","author":"Y Dong","year":"2015","unstructured":"Dong Y, Dong P, Huang D, Mei L, Xia Y, Wang Z et al (2015) Fabrication and characterization of silk fibroin-coated liposomes for ocular drug delivery. Eur J Pharm Biopharm 91:82\u201390","journal-title":"Eur J Pharm Biopharm"},{"issue":"11","key":"84_CR45","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1167\/iovs.04-0496","volume":"45","author":"JR Dunlevy","year":"2004","unstructured":"Dunlevy JR, Rada JA (2004) Interaction of lumican with aggrecan in the aging human sclera. Invest Ophthalmol Vis Sci 45(11):3849\u20133856","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"84_CR46","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1007\/s11095-008-9728-7","volume":"26","author":"C Durairaj","year":"2009","unstructured":"Durairaj C, Shah JC, Senapati S, Kompella UB (2009a) Prediction of vitreal half-life based on drug physicochemical properties: quantitative structure-pharmacokinetic relationships (QSPKR). Pharm Res 26(5):1236\u20131260","journal-title":"Pharm Res"},{"issue":"10","key":"84_CR47","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.1167\/iovs.09-3565","volume":"50","author":"C Durairaj","year":"2009","unstructured":"Durairaj C, Kim SJ, Edelhauser HF, Shah JC, Kompella UB (2009b) Influence of dosage form on the intravitreal pharmacokinetics of diclofenac. Invest Ophthalmol Vis Sci 50(10):4887\u20134897","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"84_CR48","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1167\/iovs.10-5388","volume":"51","author":"C Durairaj","year":"2010","unstructured":"Durairaj C, Kadam RS, Chandler JW, Hutcherson SL, Kompella UB (2010) Nanosized dendritic polyguanidilyated translocators for enhanced solubility, permeability, and delivery of gatifloxacin. Invest Ophthalmol Vis Sci 51(11):5804\u20135816","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"84_CR49","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1517\/14712598.3.1.45","volume":"3","author":"S Duvvuri","year":"2003","unstructured":"Duvvuri S, Majumdar S, Mitra AK (2003) Drug delivery to the retina: challenges and opportunities. Expert Opin Biol Ther 3(1):45\u201356","journal-title":"Expert Opin Biol Ther"},{"issue":"3","key":"84_CR50","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jconrel.2005.09.049","volume":"110","author":"E Eljarrat-Binstock","year":"2006","unstructured":"Eljarrat-Binstock E, Domb AJ (2006) Iontophoresis: a non-invasive ocular drug delivery. J Control Release 110(3):479\u2013489","journal-title":"J Control Release"},{"issue":"4","key":"84_CR51","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s11095-009-0042-9","volume":"27","author":"E Eljarrat-Binstock","year":"2010","unstructured":"Eljarrat-Binstock E, Pe\u2019er J, Domb AJ (2010) New techniques for drug delivery to the posterior eye segment. Pharm Res 27(4):530\u2013543","journal-title":"Pharm Res"},{"issue":"1\u20132","key":"84_CR52","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ijpharm.2007.10.054","volume":"352","author":"S Eperon","year":"2008","unstructured":"Eperon S, Bossy-Nobs L, Petropoulos IK, Gurny R, Guex-Crosier Y (2008) A biodegradable drug delivery system for the treatment of postoperative inflammation. Int J Pharm 352(1\u20132):240\u2013247","journal-title":"Int J Pharm"},{"key":"84_CR53","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0074-7696(08)62148-8","volume":"190","author":"GD Eytan","year":"1999","unstructured":"Eytan GD, Kuchel PW (1999) Mechanism of action of P-glycoprotein in relation to passive membrane permeation. Int Rev Cytol 190:175\u2013250","journal-title":"Int Rev Cytol"},{"issue":"1\u20132","key":"84_CR54","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.ijpharm.2012.07.024","volume":"436","author":"T Fujisawa","year":"2012","unstructured":"Fujisawa T, Miyai H, Hironaka K, Tsukamoto T, Tahara K, Tozuka Y et al (2012) Liposomal diclofenac eye drop formulations targeting the retina: formulation stability improvement using surface modification of liposomes. Int J Pharm 436(1\u20132):564\u2013567","journal-title":"Int J Pharm"},{"issue":"2","key":"84_CR55","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1167\/iovs.08-2370","volume":"50","author":"E Furrer","year":"2009","unstructured":"Furrer E, Berdugo M, Stella C, Behar-Cohen F, Gurny R, Feige U et al (2009) Pharmacokinetics and posterior segment biodistribution of ESBA105, an anti-TNF-alpha single-chain antibody, upon topical administration to the rabbit eye. Invest Ophthalmol Vis Sci 50(2):771\u2013778","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1\u20132","key":"84_CR56","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijpharm.2008.08.004","volume":"365","author":"L Gan","year":"2009","unstructured":"Gan L, Gan Y, Zhu C, Zhang X, Zhu J (2009) Novel microemulsion in situ electrolyte-triggered gelling system for ophthalmic delivery of lipophilic cyclosporine A: in vitro and in vivo results. Int J Pharm 365(1\u20132):143\u2013149","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"84_CR57","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijpharm.2010.06.015","volume":"396","author":"L Gan","year":"2010","unstructured":"Gan L, Han S, Shen J, Zhu J, Zhu C, Zhang X et al (2010) Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: improving preocular retention and ocular bioavailability. Int J Pharm 396(1\u20132):179\u2013187","journal-title":"Int J Pharm"},{"issue":"5","key":"84_CR58","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s11095-008-9694-0","volume":"26","author":"R Gaudana","year":"2009","unstructured":"Gaudana R, Jwala J, Boddu SHS, Mitra AK (2009) Recent perspectives in ocular drug delivery. Pharm Res 26(5):1197\u20131216","journal-title":"Pharm Res"},{"issue":"3","key":"84_CR59","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","volume":"12","author":"R Gaudana","year":"2010","unstructured":"Gaudana R, Ananthula HK, Parenky A, Mitra AK (2010) Ocular drug delivery. AAPS J 12(3):348\u2013360","journal-title":"AAPS J"},{"issue":"2","key":"84_CR60","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1517\/17425247.3.2.275","volume":"3","author":"D Ghate","year":"2006","unstructured":"Ghate D, Edelhauser HF (2006) Ocular drug delivery. Expert Opin Drug Deliv 3(2):275\u2013287","journal-title":"Expert Opin Drug Deliv"},{"issue":"3","key":"84_CR61","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00439-016-1637-y","volume":"135","author":"NG Ghazi","year":"2016","unstructured":"Ghazi NG, Abboud EB, Nowilaty SR, Alkuraya H, Alhommadi A, Cai H et al (2016) Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phase I trial. Hum Genet 135(3):327\u2013343","journal-title":"Hum Genet"},{"issue":"4","key":"84_CR62","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1167\/iovs.13-11747","volume":"54","author":"BC Gilger","year":"2013","unstructured":"Gilger BC, Abarca EM, Salmon JH, Patel S (2013) Treatment of acute posterior uveitis in a porcine model by injection of triamcinolone acetonide into the suprachoroidal space using microneedles. Invest Ophthalmol Vis Sci 54(4):2483\u20132492","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"84_CR63","first-page":"21","volume":"5","author":"JM Gu","year":"1988","unstructured":"Gu JM, Robinson JR, Leung SH (1988) Binding of acrylic polymers to mucin\/epithelial surfaces: structure-property relationships. Crit Rev Ther Drug Carrier Syst 5(1):21\u201367","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"issue":"1","key":"84_CR64","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2174\/156720108783331050","volume":"5","author":"B Guidetti","year":"2008","unstructured":"Guidetti B, Azema J, Malet-Martino M, Martino R (2008) Delivery systems for the treatment of proliferative vitreoretinopathy: materials, devices and colloidal carriers. Curr Drug Deliv 5(1):7\u201319","journal-title":"Curr Drug Deliv"},{"issue":"1","key":"84_CR65","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jconrel.2010.11.009","volume":"150","author":"C Gupta","year":"2011","unstructured":"Gupta C, Chauhan A (2011) Ophthalmic delivery of cyclosporine A by punctal plugs. J Control Release 150(1):70\u201376","journal-title":"J Control Release"},{"issue":"1\u20132","key":"84_CR66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(00)00508-1","volume":"209","author":"AK Gupta","year":"2000","unstructured":"Gupta AK, Madan S, Majumdar DK, Maitra A (2000) Ketorolac entrapped in polymeric micelles: preparation, characterisation and ocular anti-inflammatory studies. Int J Pharm 209(1\u20132):1\u201314","journal-title":"Int J Pharm"},{"issue":"6","key":"84_CR67","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/1061186X.2010.504268","volume":"19","author":"H Gupta","year":"2011","unstructured":"Gupta H, Aqil M, Khar RK, Ali A, Bhatnagar A, Mittal G (2011) Biodegradable levofloxacin nanoparticles for sustained ocular drug delivery. J Drug Target 19(6):409\u2013417","journal-title":"J Drug Target"},{"issue":"8","key":"84_CR68","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1755-3768.2009.01584.x","volume":"88","author":"FS Habib","year":"2010","unstructured":"Habib FS, Fouad EA, Abdel-Rhaman MS, Fathalla D (2010) Liposomes as an ocular delivery system of fluconazole: in-vitro studies. Acta Ophthalmol 88(8):901\u2013904","journal-title":"Acta Ophthalmol"},{"key":"84_CR69","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.exer.2003.10.017","volume":"78","author":"M Halhal","year":"2004","unstructured":"Halhal M, Renard G, Courtois Y, BenEzra D, Behar-Cohen F (2004) Iontophoresis: from the lab to the bed side. Exp Eye Res 78:751\u2013757","journal-title":"Exp Eye Res"},{"issue":"10","key":"84_CR70","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1089\/hum.2008.107","volume":"19","author":"WW Hauswirth","year":"2008","unstructured":"Hauswirth WW, Aleman TS, Kaushal S, Cideciyan AV, Schwartz SB, Wang L et al (2008) Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial. Hum Gene Ther 19(10):979\u2013990","journal-title":"Hum Gene Ther"},{"issue":"7","key":"84_CR71","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/bjo.58.7.674","volume":"58","author":"JS Hillman","year":"1974","unstructured":"Hillman JS (1974) Management of acute glaucoma with pilocarpine-soaked hydrophilic lens. Br J Ophthalmol 58(7):674\u2013679","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"84_CR72","first-page":"1940","volume":"31","author":"JA Hobden","year":"1990","unstructured":"Hobden JA, Reidy JJ, O\u2019Callaghan RJ, Insler MS, Hill JM (1990) Ciprofloxacin iontophoresis for aminoglycoside-resistant pseudomonal keratitis. Invest Ophthalmol Vis Sci 31(10):1940\u20131944","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"84_CR73","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.nano.2011.08.018","volume":"8","author":"CA Holden","year":"2012","unstructured":"Holden CA, Tyagi P, Thakur A, Kadam R, Jadhav G, Kompella UB et al (2012) Polyamidoamine dendrimer hydrogel for enhanced delivery of antiglaucoma drugs. Nanomed Nanotechnol Biol Med 8(5):776\u2013783","journal-title":"Nanomed Nanotechnol Biol Med"},{"issue":"1","key":"84_CR74","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ijpharm.2015.08.024","volume":"494","author":"G Horvat","year":"2015","unstructured":"Horvat G, Budai-Szucs M, Berko S, Szabo-Revesz P, Soos J, Facsko A et al (2015) Comparative study of nanosized cross-linked sodium-, linear sodium- and zinc-hyaluronate as potential ocular mucoadhesive drug delivery systems. Int J Pharm 494(1):321\u2013328","journal-title":"Int J Pharm"},{"issue":"7","key":"84_CR75","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1076\/ceyr.16.7.693.5059","volume":"16","author":"K Hosoya","year":"1997","unstructured":"Hosoya K, Lee VH (1997) Cidofovir transport in the pigmented rabbit conjunctiva. Curr Eye Res 16(7):693\u2013697","journal-title":"Curr Eye Res"},{"key":"84_CR76","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/978-1-4614-4711-5_4","volume":"763","author":"K Hosoya","year":"2012","unstructured":"Hosoya K, Tachikawa M (2012) The inner blood-retinal barrier: molecular structure and transport biology. Adv Exp Med Biol 763:85\u2013104","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"84_CR77","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1006\/exer.1997.0354","volume":"65","author":"K Hosoya","year":"1997","unstructured":"Hosoya K, Horibe Y, Kim KJ, Lee VH (1997) Na(+)-dependent L-arginine transport in the pigmented rabbit conjunctiva. Exp Eye Res 65(4):547\u2013553","journal-title":"Exp Eye Res"},{"issue":"2","key":"84_CR78","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ejpb.2004.12.007","volume":"60","author":"K Hosoya","year":"2005","unstructured":"Hosoya K, Lee VH, Kim KJ (2005) Roles of the conjunctiva in ocular drug delivery: a review of conjunctival transport mechanisms and their regulation. Eur J Pharm Biopharm 60(2):227\u2013240","journal-title":"Eur J Pharm Biopharm"},{"issue":"12","key":"84_CR79","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1517\/17425247.2011.628983","volume":"8","author":"K Hosoya","year":"2011","unstructured":"Hosoya K, Tomi M, Tachikawa M (2011) Strategies for therapy of retinal diseases using systemic drug delivery: relevance of transporters at the blood-retinal barrier. Expert Opin Drug Deliv 8(12):1571\u20131587","journal-title":"Expert Opin Drug Deliv"},{"key":"84_CR80","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ejpb.2015.06.001","volume":"94","author":"KH Hsu","year":"2015","unstructured":"Hsu KH, Carbia BE, Plummer C, Chauhan A (2015) Dual drug delivery from vitamin E loaded contact lenses for glaucoma therapy. Eur J Pharm Biopharm 94:312\u2013321","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"84_CR81","first-page":"194","volume":"61","author":"FQ Hu","year":"2006","unstructured":"Hu FQ, Li YH, Yuan H, Zeng S (2006) Novel self-aggregates of chitosan oligosaccharide grafted stearic acid: preparation, characterization and protein association. Pharmazie 61(3):194\u2013198","journal-title":"Pharmazie"},{"issue":"3","key":"84_CR82","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1177\/153303460500400308","volume":"4","author":"Z Huang","year":"2005","unstructured":"Huang Z (2005) A review of progress in clinical photodynamic therapy. Technol Cancer Res Treat 4(3):283\u2013293","journal-title":"Technol Cancer Res Treat"},{"issue":"4","key":"84_CR83","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/jop.1993.9.299","volume":"9","author":"PM Hughes","year":"1993","unstructured":"Hughes PM, Mitra AK (1993) Effect of acylation on the ocular disposition of acyclovir. II: corneal permeability and anti-HSV 1 activity of 2\u2032-esters in rabbit epithelial keratitis. J Ocul Pharmacol 9(4):299\u2013309","journal-title":"J Ocul Pharmacol"},{"issue":"14","key":"84_CR84","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.addr.2005.09.004","volume":"57","author":"PM Hughes","year":"2005","unstructured":"Hughes PM, Olejnik O, Chang-Lin JE, Wilson CG (2005) Topical and systemic drug delivery to the posterior segments. Adv Drug Deliv Rev 57(14):2010\u20132032","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"84_CR85","first-page":"81","volume":"5","author":"A Hui","year":"2012","unstructured":"Hui A, Sheardown H, Jones L (2012) Acetic and acrylic acid molecular imprinted model silicone hydrogel materials for ciprofloxacin-hcl delivery. Materials 5(1):81\u2013107","journal-title":"Materials"},{"issue":"2","key":"84_CR86","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1021\/mp900279c","volume":"7","author":"HK Ibrahim","year":"2010","unstructured":"Ibrahim HK, El-Leithy IS, Makky AA (2010) Mucoadhesive nanoparticles as carrier systems for prolonged ocular delivery of gatifloxacin\/prednisolone bitherapy. Mol Pharm 7(2):576\u2013585","journal-title":"Mol Pharm"},{"issue":"12","key":"84_CR87","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1021\/nl051679d","volume":"5","author":"R Ideta","year":"2005","unstructured":"Ideta R, Tasaka F, Jang WD, Nishiyama N, Zhang GD, Harada A et al (2005) Nanotechnology-based photodynamic therapy for neovascular disease using a supramolecular nanocarrier loaded with a dendritic photosensitizer. Nano Lett 5(12):2426\u20132431","journal-title":"Nano Lett"},{"issue":"5","key":"84_CR88","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1167\/iovs.02-1027","volume":"44","author":"TL Jackson","year":"2003","unstructured":"Jackson TL, Antcliff R, Hillenkamp J, Marshall J (2003) Human retinal molecular weight exclusion limit and estimate of species variation. Invest Ophthalmol Vis Sci 44(5):2141\u20132146","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"84_CR89","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.ophtha.2006.02.021","volume":"113","author":"GJ Jaffe","year":"2006","unstructured":"Jaffe GJ, Martin D, Callanan D, Pearson PA, Levy B, Comstock T et al (2006) Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis - thirty-four-week results of a multicenter randomized clinical study. Ophthalmology 113(6):1020\u20131027","journal-title":"Ophthalmology"},{"issue":"7","key":"84_CR90","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1167\/iovs.02-0907","volume":"44","author":"B Jain-Vakkalagadda","year":"2003","unstructured":"Jain-Vakkalagadda B, Dey S, Pal D, Mitra AK (2003) Identification and functional characterization of a Na+-independent large neutral amino acid transporter, LAT1, in human and rabbit cornea. Invest Ophthalmol Vis Sci 44(7):2919\u20132927","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"84_CR91","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1021\/mp0499499","volume":"1","author":"B Jain-Vakkalagadda","year":"2004","unstructured":"Jain-Vakkalagadda B, Pal D, Gunda S, Nashed Y, Ganapathy V, Mitra AK (2004) Identification of a Na+-dependent cationic and neutral amino acid transporter, B(0,+), in human and rabbit cornea. Mol Pharm 1(5):338\u2013346","journal-title":"Mol Pharm"},{"issue":"10","key":"84_CR92","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1080\/02713680600900206","volume":"31","author":"KG Janoria","year":"2006","unstructured":"Janoria KG, Hariharan S, Paturi D, Pal D, Mitra AK (2006) Biotin uptake by rabbit corneal epithelial cells: role of sodium-dependent multivitamin transporter (SMVT). Curr Eye Res 31(10):797\u2013809","journal-title":"Curr Eye Res"},{"issue":"2","key":"84_CR93","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s11095-008-9756-3","volume":"26","author":"J Jiang","year":"2009","unstructured":"Jiang J, Moore JS, Edelhauser HF, Prausnitz MR (2009) Intrascleral drug delivery to the eye using hollow microneedles. Pharm Res 26(2):395\u2013403","journal-title":"Pharm Res"},{"issue":"7","key":"84_CR94","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.biomaterials.2011.10.076","volume":"33","author":"HJ Jung","year":"2012","unstructured":"Jung HJ, Chauhan A (2012) Temperature sensitive contact lenses for triggered ophthalmic drug delivery. Biomaterials 33(7):2289\u20132300","journal-title":"Biomaterials"},{"key":"84_CR95","doi-asserted-by":"crossref","unstructured":"Kambhampati SP, Mishra MK, Mastorakos P, Oh Y, Lutty GA, Kannan RM (2015) Intracellular delivery of dendrimer triamcinolone acetonide conjugates into microglial and human retinal pigment epithelial cells. Eur J Pharm Biopharm 95(Pt B):239\u2013249","DOI":"10.1016\/j.ejpb.2015.02.013"},{"issue":"8","key":"84_CR96","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1001\/archophthalmol.2009.185","volume":"127","author":"SJ Kang","year":"2009","unstructured":"Kang SJ, Durairaj C, Kompella UB, O\u2019Brien JM, Grossniklaus HE (2009) Subconjunctival nanoparticle carboplatin in the treatment of murine retinoblastoma. Arch Ophthalmol 127(8):1043\u20131047","journal-title":"Arch Ophthalmol"},{"issue":"1\u20132","key":"84_CR97","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0378-5173(03)00124-8","volume":"257","author":"CC Karlgard","year":"2003","unstructured":"Karlgard CC, Wong NS, Jones LW, Moresoli C (2003) In vitro uptake and release studies of ocular pharmaceutical agents by silicon-containing and p-HEMA hydrogel contact lens materials. Int J Pharm 257(1\u20132):141\u2013151","journal-title":"Int J Pharm"},{"key":"84_CR98","first-page":"3791","volume":"9","author":"PR Karn","year":"2014","unstructured":"Karn PR, Kim HD, Kang H, Sun BK, Jin SE, Hwang SJ (2014) Supercritical fluid-mediated liposomes containing cyclosporin A for the treatment of dry eye syndrome in a rabbit model: comparative study with the conventional cyclosporin A emulsion. Int J Nanomedicine 9:3791\u20133800","journal-title":"Int J Nanomedicine"},{"issue":"1\u20132","key":"84_CR99","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijpharm.2007.03.011","volume":"340","author":"MA Kassem","year":"2007","unstructured":"Kassem MA, Abdel Rahman AA, Ghorab MM, Ahmed MB, Khalil RM (2007) Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs. Int J Pharm 340(1\u20132):126\u2013133","journal-title":"Int J Pharm"},{"key":"84_CR100","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.carbpol.2013.10.079","volume":"102","author":"S Katiyar","year":"2014","unstructured":"Katiyar S, Pandit J, Mondal RS, Mishra AK, Chuttani K, Aqil M et al (2014) In situ gelling dorzolamide loaded chitosan nanoparticles for the treatment of glaucoma. Carbohydr Polym 102:117\u2013124","journal-title":"Carbohydr Polym"},{"issue":"2","key":"84_CR101","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1089\/jop.2006.22.110","volume":"22","author":"S Katragadda","year":"2006","unstructured":"Katragadda S, Talluri RS, Mitra AK (2006) Modulation of P-glycoprotein-mediated efflux by prodrug derivatization: an approach involving peptide transporter-mediated influx across rabbit cornea. J Ocul Pharmacol Ther 22(2):110\u2013120","journal-title":"J Ocul Pharmacol Ther"},{"issue":"4","key":"84_CR102","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1081\/DDC-120002997","volume":"28","author":"IP Kaur","year":"2002","unstructured":"Kaur IP, Smitha R (2002) Penetration enhancers and ocular bioadhesives: two new avenues for ophthalmic drug delivery. Drug Dev Ind Pharm 28(4):353\u2013369","journal-title":"Drug Dev Ind Pharm"},{"issue":"10","key":"84_CR103","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.ophtha.2011.07.027","volume":"118","author":"JH Kempen","year":"2011","unstructured":"Kempen JH, Altaweel MM, Holbrook JT, Jabs DA, Louis TA, Sugar EA et al (2011) Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial. Ophthalmology 118(10):1916\u20131926","journal-title":"Ophthalmology"},{"issue":"1\u20132","key":"84_CR104","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ijpharm.2012.08.016","volume":"437","author":"W Khan","year":"2012","unstructured":"Khan W, Aldouby YH, Avramoff A, Domb AJ (2012) Cyclosporin nanosphere formulation for ophthalmic administration. Int J Pharm 437(1\u20132):275\u2013276","journal-title":"Int J Pharm"},{"issue":"1","key":"84_CR105","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ophtha.2013.06.033","volume":"121","author":"RN Khurana","year":"2014","unstructured":"Khurana RN, Appa SN, McCannel CA, Elman MJ, Wittenberg SE, Parks DJ et al (2014) Dexamethasone implant anterior chamber migration risk factors, complications, and management strategies. Ophthalmology 121(1):67\u201371","journal-title":"Ophthalmology"},{"issue":"5","key":"84_CR106","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000108117","volume":"39","author":"SH Kim","year":"2007","unstructured":"Kim SH, Lutz RJ, Wang NS, Robinson MR (2007) Transport barriers in transscleral drug delivery for retinal diseases. Ophthalmic Res 39(5):244\u2013254","journal-title":"Ophthalmic Res"},{"key":"84_CR107","doi-asserted-by":"crossref","unstructured":"Kirchhof S, Goepferich AM, Brandl FP (2015) Hydrogels in ophthalmic applications. Eur J Pharm Biopharm 95(Pt B):227\u2013238","DOI":"10.1016\/j.ejpb.2015.05.016"},{"issue":"4","key":"84_CR108","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1081\/PDT-100102035","volume":"5","author":"S Klang","year":"2000","unstructured":"Klang S, Abdulrazik M, Benita S (2000) Influence of emulsion droplet surface charge on indomethacin ocular tissue distribution. Pharm Dev Technol 5(4):521\u2013532","journal-title":"Pharm Dev Technol"},{"issue":"3","key":"84_CR109","doi-asserted-by":"crossref","first-page":"435","DOI":"10.4155\/tde.10.40","volume":"1","author":"UB Kompella","year":"2010","unstructured":"Kompella UB, Kadam RS, Lee VH (2010) Recent advances in ophthalmic drug delivery. Ther Deliv 1(3):435\u2013456","journal-title":"Ther Deliv"},{"key":"84_CR110","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.preteyeres.2013.04.001","volume":"36","author":"UB Kompella","year":"2013","unstructured":"Kompella UB, Amrite AC, Pacha Ravi R, Durazo SA (2013) Nanomedicines for back of the eye drug delivery, gene delivery, and imaging. Prog Retin Eye Res 36:172\u2013198","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"84_CR111","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1021\/mp200155t","volume":"8","author":"G Konat Zorzi","year":"2011","unstructured":"Konat Zorzi G, Contreras-Ruiz L, Parraga JE, Lopez-Garcia A, Romero Bello R, Diebold Y et al (2011) Expression of MUC5AC in ocular surface epithelial cells using cationized gelatin nanoparticles. Mol Pharm 8(5):1783\u20131788","journal-title":"Mol Pharm"},{"issue":"1","key":"84_CR112","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3390\/polym3010193","volume":"3","author":"N Kuno","year":"2011","unstructured":"Kuno N, Fujii S (2011) Recent advances in ocular drug delivery systems. Polymers (Basel) 3(1):193\u2013221","journal-title":"Polymers (Basel)"},{"issue":"1","key":"84_CR113","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1023\/A:1013671819604","volume":"19","author":"M Kuwano","year":"2002","unstructured":"Kuwano M, Ibuki H, Morikawa N, Ota A, Kawashima Y (2002) Cyclosporine A formulation affects its ocular distribution in rabbits. Pharm Res 19(1):108\u2013111","journal-title":"Pharm Res"},{"issue":"1\u20132","key":"84_CR114","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijpharm.2004.12.015","volume":"295","author":"F Lallemand","year":"2005","unstructured":"Lallemand F, Furrer P, Felt-Baeyens O, Gex-Fabry M, Dumont JM, Besseghir K et al (2005) A novel water-soluble cyclosporine A prodrug: ocular tolerance and in vivo kinetics. Int J Pharm 295(1\u20132):7\u201314","journal-title":"Int J Pharm"},{"issue":"2","key":"84_CR115","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ejpb.2007.03.011","volume":"67","author":"F Lallemand","year":"2007","unstructured":"Lallemand F, Varesio E, Felt-Baeyens O, Bossy L, Hopfgartner G, Gurny R (2007) Biological conversion of a water-soluble prodrug of cyclosporine A. Eur J Pharm Biopharm 67(2):555\u2013561","journal-title":"Eur J Pharm Biopharm"},{"issue":"1\u20132","key":"84_CR116","first-page":"135","volume":"63","author":"SL Law","year":"2000","unstructured":"Law SL, Huang KJ, Chiang CH (2000) Acyclovir-containing liposomes for potential ocular delivery. Corneal penetration and absorption. J Control Release 63(1\u20132):135\u2013140","journal-title":"J Control Release"},{"issue":"3","key":"84_CR117","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/jps.2600720310","volume":"72","author":"VH Lee","year":"1983","unstructured":"Lee VH (1983) Esterase activities in adult rabbit eyes. J Pharm Sci 72(3):239\u2013244","journal-title":"J Pharm Sci"},{"issue":"1","key":"84_CR118","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/jop.1986.2.67","volume":"2","author":"VH Lee","year":"1986","unstructured":"Lee VH, Robinson JR (1986) Topical ocular drug delivery: recent developments and future challenges. J Ocul Pharmacol 2(1):67\u2013108","journal-title":"J Ocul Pharmacol"},{"key":"84_CR119","first-page":"527516","volume":"2012","author":"JH Lee","year":"2012","unstructured":"Lee JH, Pidaparti RM, Atkinson GM, Moorthy RS (2012) Design of an implantable device for ocular drug delivery. J Drug Deliv 2012:527516","journal-title":"J Drug Deliv"},{"issue":"1","key":"84_CR120","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ijpharm.2009.06.020","volume":"379","author":"N Li","year":"2009","unstructured":"Li N, Zhuang C, Wang M, Sun X, Nie S, Pan W (2009) Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery. Int J Pharm 379(1):131\u2013138","journal-title":"Int J Pharm"},{"issue":"5","key":"84_CR121","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s10544-009-9313-9","volume":"11","author":"R Lo","year":"2009","unstructured":"Lo R, Li PY, Saati S, Agrawal RN, Humayun MS, Meng E (2009) A passive MEMS drug delivery pump for treatment of ocular diseases. Biomed Microdevices 11(5):959\u2013970","journal-title":"Biomed Microdevices"},{"issue":"8","key":"84_CR122","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.2042-7158.1991.tb03534.x","volume":"43","author":"C Losa","year":"1991","unstructured":"Losa C, Calvo P, Castro E, Vila-Jato JL, Alonso MJ (1991) Improvement of ocular penetration of amikacin sulphate by association to poly(butylcyanoacrylate) nanoparticles. J Pharm Pharmacol 43(8):548\u2013552","journal-title":"J Pharm Pharmacol"},{"issue":"1","key":"84_CR123","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1023\/A:1018977130559","volume":"10","author":"C Losa","year":"1993","unstructured":"Losa C, Marchal-Heussler L, Orallo F, Vila Jato JL, Alonso MJ (1993) Design of new formulations for topical ocular administration: polymeric nanocapsules containing metipranolol. Pharm Res 10(1):80\u201387","journal-title":"Pharm Res"},{"issue":"2","key":"84_CR124","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/jps.23390","volume":"102","author":"C Lu","year":"2013","unstructured":"Lu C, Yoganathan RB, Kociolek M, Allen C (2013) Hydrogel containing silica shell cross-linked micelles for ocular drug delivery. J Pharm Sci 102(2):627\u2013637","journal-title":"J Pharm Sci"},{"issue":"1\u20132","key":"84_CR125","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijpharm.2010.10.013","volume":"403","author":"Q Luo","year":"2011","unstructured":"Luo Q, Zhao J, Zhang X, Pan W (2011) Nanostructured lipid carrier (NLC) coated with Chitosan Oligosaccharides and its potential use in ocular drug delivery system. Int J Pharm 403(1\u20132):185\u2013191","journal-title":"Int J Pharm"},{"issue":"4","key":"84_CR126","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10439-006-9238-x","volume":"35","author":"F Mac Gabhann","year":"2007","unstructured":"Mac Gabhann F, Demetriades AM, Deering T, Packer JD, Shah SM, Duh E et al (2007) Protein transport to choroid and retina following periocular injection: theoretical and experimental study. Ann Biomed Eng 35(4):615\u2013630","journal-title":"Ann Biomed Eng"},{"key":"84_CR127","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1201\/9780203912072.pt1","volume-title":"Ophthalmic drug delivery systems","author":"S Macha","year":"2003","unstructured":"Macha S, Mitra AK (2003) Overview of ocular drug delivery. In: Mitra AK (ed) Ophthalmic drug delivery systems, 2nd edn. Marcel Dekker, New York, pp 1\u201312","edition":"2"},{"issue":"13","key":"84_CR128","doi-asserted-by":"crossref","first-page":"5464","DOI":"10.1021\/jm4004939","volume":"56","author":"N Mainolfi","year":"2013","unstructured":"Mainolfi N, Powers J, Amin J, Long D, Lee W, McLaughlin ME et al (2013) An effective prodrug strategy to selectively enhance ocular exposure of a cannabinoid receptor (CB1\/2) agonist. J Med Chem 56(13):5464\u20135472","journal-title":"J Med Chem"},{"issue":"2","key":"84_CR129","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1208\/s12249-011-9643-9","volume":"12","author":"S Maiti","year":"2011","unstructured":"Maiti S, Paul S, Mondol R, Ray S, Sa B (2011) Nanovesicular formulation of brimonidine tartrate for the management of glaucoma: in vitro and in vivo evaluation. AAPS PharmSciTech 12(2):755\u2013763","journal-title":"AAPS PharmSciTech"},{"issue":"6","key":"84_CR130","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1089\/jop.2005.21.463","volume":"21","author":"S Majumdar","year":"2005","unstructured":"Majumdar S, Nashed YE, Patel K, Jain R, Itahashi M, Neumann DM et al (2005) Dipeptide monoester ganciclovir prodrugs for treating HSV-1-induced corneal epithelial and stromal keratitis: in vitro and in vivo evaluations. J Ocul Pharmacol Ther 21(6):463\u2013474","journal-title":"J Ocul Pharmacol Ther"},{"issue":"11","key":"84_CR131","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.addr.2006.07.024","volume":"58","author":"E Mannermaa","year":"2006","unstructured":"Mannermaa E, Vellonen KS, Urtti A (2006) Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics. Adv Drug Deliv Rev 58(11):1136\u20131163","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"84_CR132","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1006\/bbrc.1996.0326","volume":"219","author":"T Matsuo","year":"1996","unstructured":"Matsuo T, Masuda I, Yasuda T, Matsuo N (1996) Gene transfer to the retina of rat by liposome eye drops. Biochem Biophys Res Commun 219(3):947\u2013950","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"84_CR133","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3109\/03639040903099751","volume":"36","author":"MM Mehanna","year":"2010","unstructured":"Mehanna MM, Elmaradny HA, Samaha MW (2010) Mucoadhesive liposomes as ocular delivery system: physical, microbiological, and in vivo assessment. Drug Dev Ind Pharm 36(1):108\u2013118","journal-title":"Drug Dev Ind Pharm"},{"issue":"4","key":"84_CR134","first-page":"504","volume":"21","author":"S Mishima","year":"1981","unstructured":"Mishima S (1981) Clinical pharmacokinetics of the eye. Proctor lecture. Invest Ophthalmol Vis Sci 21(4):504\u2013541","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"84_CR135","unstructured":"Mitra AK, Velagaleti PR, Grau UM (2010) Topical drug delivery systems for ophthalmic use. Google Patents"},{"issue":"9","key":"84_CR136","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106653","volume":"9","author":"S Mohammadi","year":"2014","unstructured":"Mohammadi S, Jones L, Gorbet M (2014) Extended latanoprost release from commercial contact lenses: in vitro studies using corneal models. PLoS One 9(9), e106653","journal-title":"PLoS One"},{"issue":"2","key":"84_CR137","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/jps.21003","volume":"97","author":"SA Molokhia","year":"2008","unstructured":"Molokhia SA, Jeong EK, Higuchi WI, Li SK (2008) Examination of barriers and barrier alteration in transscleral iontophoresis. J Pharm Sci 97(2):831\u2013844","journal-title":"J Pharm Sci"},{"issue":"3","key":"84_CR138","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.exer.2008.10.010","volume":"88","author":"SA Molokhia","year":"2009","unstructured":"Molokhia SA, Jeong EK, Higuchi WI, Li SK (2009) Transscleral iontophoretic and intravitreal delivery of a macromolecule: study of ocular distribution in vivo and postmortem with MRI. Exp Eye Res 88(3):418\u2013425","journal-title":"Exp Eye Res"},{"issue":"7","key":"84_CR139","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.visres.2009.10.013","volume":"50","author":"SA Molokhia","year":"2010","unstructured":"Molokhia SA, Sant H, Simonis J, Bishop CJ, Burr RM, Gale BK et al (2010) The capsule drug device: novel approach for drug delivery to the eye. Vision Res 50(7):680\u2013685","journal-title":"Vision Res"},{"issue":"2","key":"84_CR140","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1089\/jop.2012.0241","volume":"29","author":"SA Molokhia","year":"2013","unstructured":"Molokhia SA, Thomas SC, Garff KJ, Mandell KJ, Wirostko BM (2013) Anterior eye segment drug delivery systems: current treatments and future challenges. J Ocul Pharmacol Ther 29(2):92\u2013105","journal-title":"J Ocul Pharmacol Ther"},{"issue":"1","key":"84_CR141","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0378-5173(99)00348-8","volume":"198","author":"AS Monem","year":"2000","unstructured":"Monem AS, Ali FM, Ismail MW (2000) Prolonged effect of liposomes encapsulating pilocarpine HCl in normal and glaucomatous rabbits. Int J Pharm 198(1):29\u201338","journal-title":"Int J Pharm"},{"issue":"4","key":"84_CR142","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/jphp.12131","volume":"66","author":"RM Moosa","year":"2014","unstructured":"Moosa RM, Choonara YE, du Toit LC, Kumar P, Carmichael T, Tomar LK et al (2014) A review of topically administered mini-tablets for drug delivery to the anterior segment of the eye. J Pharm Pharmacol 66(4):490\u2013506","journal-title":"J Pharm Pharmacol"},{"issue":"3","key":"84_CR143","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1159\/000267160","volume":"24","author":"S Muchtar","year":"1992","unstructured":"Muchtar S, Almog S, Torracca MT, Saettone MF, Benita S (1992) A submicron emulsion as ocular vehicle for delta-8-tetrahydrocannabinol: effect on intraocular pressure in rabbits. Ophthalmic Res 24(3):142\u2013149","journal-title":"Ophthalmic Res"},{"issue":"1","key":"84_CR144","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0378-5173(99)00265-3","volume":"190","author":"MS Nagarsenker","year":"1999","unstructured":"Nagarsenker MS, Londhe VY, Nadkarni GD (1999) Preparation and evaluation of liposomal formulations of tropicamide for ocular delivery. Int J Pharm 190(1):63\u201371","journal-title":"Int J Pharm"},{"key":"84_CR145","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1002\/app.35229","volume":"124","author":"KL Nair","year":"2012","unstructured":"Nair KL, Vidyanand S, James J, Kumar GSV (2012) Pilocarpine-loaded poly(DLlactic-co-glycolic acid) nanoparticles as potential candidates for controlled drug delivery with enhanced ocular pharmacological response. J Appl Polym Sci 124:2030\u20132036","journal-title":"J Appl Polym Sci"},{"key":"84_CR146","unstructured":"NeurotechUSA. Available from: http:\/\/www.neurotechusa.com\/cntfrenexus.html"},{"issue":"4\u20135","key":"84_CR147","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ejps.2008.11.012","volume":"36","author":"S Nicoli","year":"2009","unstructured":"Nicoli S, Ferrari G, Quarta M, Macaluso C, Santi P (2009) In vitro transscleral iontophoresis of high molecular weight neutral compounds. Eur J Pharm Sci 36(4\u20135):486\u2013492","journal-title":"Eur J Pharm Sci"},{"issue":"21","key":"84_CR148","first-page":"184","volume":"11","author":"N Normand","year":"2005","unstructured":"Normand N, Valamanesh F, Savoldelli M, Mascarelli F, BenEzra D, Courtois Y et al (2005) VP22 light controlled delivery of oligonucleotides to ocular cells in vitro and in vivo. Mol Vis 11(21):184\u2013191","journal-title":"Mol Vis"},{"issue":"2","key":"84_CR149","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0002-9394(99)80096-8","volume":"125","author":"TW Olsen","year":"1998","unstructured":"Olsen TW, Aaberg SY, Geroski DH, Edelhauser HF (1998) Human sclera: thickness and surface area. Am J Ophthalmol 125(2):237\u2013241","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"84_CR150","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jconrel.2007.06.009","volume":"122","author":"L Paasonen","year":"2007","unstructured":"Paasonen L, Laaksonen T, Johans C, Yliperttula M, Kontturi K, Urth A (2007) Gold nanoparticles enable selective light-induced contents release from liposomes. J Control Release 122(1):86\u201393","journal-title":"J Control Release"},{"issue":"2","key":"84_CR151","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1089\/108076803321637672","volume":"19","author":"TM Parkinson","year":"2003","unstructured":"Parkinson TM, Ferguson E, Febbraro S, Bakhtyari A, King M, Mundasad M (2003) Tolerance of ocular iontophoresis in healthy volunteers. J Ocul Pharmacol Ther 19(2):145\u2013151","journal-title":"J Ocul Pharmacol Ther"},{"issue":"5","key":"84_CR152","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1136\/bjophthalmol-2011-300539","volume":"96","author":"D Pascolini","year":"2012","unstructured":"Pascolini D, Mariotti SP (2012) Global estimates of visual impairment: 2010. Br J Ophthalmol 96(5):614\u2013618","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"84_CR153","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1167\/iovs.12-9872","volume":"53","author":"SR Patel","year":"2012","unstructured":"Patel SR, Berezovsky DE, McCarey BE, Zarnitsyn V, Edelhauser HF, Prausnitz MR (2012) Targeted administration into the suprachoroidal space using a microneedle for drug delivery to the posterior segment of the eye. Invest Ophthalmol Vis Sci 53(8):4433\u20134441","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"84_CR154","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/ICU.0000000000000143","volume":"26","author":"W Pearce","year":"2015","unstructured":"Pearce W, Hsu J, Yeh S (2015) Advances in drug delivery to the posterior segment. Curr Opin Ophthalmol 26(3):233\u2013239","journal-title":"Curr Opin Ophthalmol"},{"key":"84_CR155","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/B978-0-323-02598-0.50119-1","volume-title":"Retina","author":"J Pederson","year":"2006","unstructured":"Pederson J (2006) Fluid physiology of the subretinal space. In: Rayan SJ (ed) Retina, 4th edn. Elsevier Inc., Philadelphia, pp 1909\u20131920","edition":"4"},{"issue":"5","key":"84_CR156","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1002\/jps.24385","volume":"104","author":"SB Pehlivan","year":"2015","unstructured":"Pehlivan SB, Yavuz B, Calamak S, Ulubayram K, Kaffashi A, Vural I et al (2015) Preparation and in vitro\/in vivo evaluation of cyclosporin A-loaded nanodecorated ocular implants for subconjunctival application. J Pharm Sci 104(5):1709\u20131720","journal-title":"J Pharm Sci"},{"issue":"1","key":"84_CR157","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jconrel.2012.06.017","volume":"162","author":"CC Peng","year":"2012","unstructured":"Peng CC, Burke MT, Carbia BE, Plummer C, Chauhan A (2012) Extended drug delivery by contact lenses for glaucoma therapy. J Control Release 162(1):152\u2013158","journal-title":"J Control Release"},{"issue":"1\u20132","key":"84_CR158","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ijpharm.2003.11.032","volume":"272","author":"I Pepic","year":"2004","unstructured":"Pepic I, Jalsenjak N, Jalsenjak I (2004) Micellar solutions of triblock copolymer surfactants with pilocarpine. Int J Pharm 272(1\u20132):57\u201364","journal-title":"Int J Pharm"},{"issue":"10","key":"84_CR159","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1002\/jps.22137","volume":"99","author":"I Pepic","year":"2010","unstructured":"Pepic I, Hafner A, Lovric J, Pirkic B, Filipovic-Grcic J (2010) A nonionic surfactant\/chitosan micelle system in an innovative eye drop formulation. J Pharm Sci 99(10):4317\u20134325","journal-title":"J Pharm Sci"},{"issue":"3","key":"84_CR160","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/00006982-198909030-00012","volume":"9","author":"GA Peyman","year":"1989","unstructured":"Peyman GA, Schulman JA, Khoobehi B, Alkan HM, Tawakol ME, Mani H (1989) Toxicity and clearance of a combination of liposome-encapsulated ganciclovir and trifluridine. Retina 9(3):232\u2013236","journal-title":"Retina"},{"issue":"4","key":"84_CR161","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1517\/17425247.2014.882315","volume":"11","author":"CM Phan","year":"2014","unstructured":"Phan CM, Subbaraman L, Jones L (2014) Contact lenses for antifungal ocular drug delivery: a review. Expert Opin Drug Deliv 11(4):537\u2013546","journal-title":"Expert Opin Drug Deliv"},{"issue":"1\u20132","key":"84_CR162","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0928-0987(02)00057-X","volume":"16","author":"R Pignatello","year":"2002","unstructured":"Pignatello R, Bucolo C, Ferrara P, Maltese A, Puleo A, Puglisi G (2002) Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen. Eur J Pharm Sci 16(1\u20132):53\u201361","journal-title":"Eur J Pharm Sci"},{"issue":"4","key":"84_CR163","doi-asserted-by":"crossref","first-page":"356","DOI":"10.4103\/0975-1483.71623","volume":"2","author":"P Prabhu","year":"2010","unstructured":"Prabhu P, Nitish KR, Koland M, Harish N, Vijayanarayan K, Dhondge G et al (2010) Preparation and evaluation of nano-vesicles of brimonidine tartrate as an ocular drug delivery system. J Young Pharm 2(4):356\u2013361","journal-title":"J Young Pharm"},{"issue":"3","key":"84_CR164","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1081\/DDC-52058","volume":"31","author":"JD Quintana-Hau","year":"2005","unstructured":"Quintana-Hau JD, Cruz-Olmos E, Lopez-Sanchez MI, Sanchez-Castellanos V, Baiza-Duran L, Gonzalez JR et al (2005) Characterization of the novel ophthalmic drug carrier Sophisen in two of its derivatives: 3A Ofteno and Modusik-A Ofteno. Drug Dev Ind Pharm 31(3):263\u2013269","journal-title":"Drug Dev Ind Pharm"},{"issue":"12","key":"84_CR165","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3109\/02713683.2010.508867","volume":"35","author":"F Rafie","year":"2010","unstructured":"Rafie F, Javadzadeh Y, Javadzadeh AR, Ghavidel LA, Jafari B, Moogooee M et al (2010) In vivo evaluation of novel nanoparticles containing dexamethasone for ocular drug delivery on rabbit eye. Curr Eye Res 35(12):1081\u20131089","journal-title":"Curr Eye Res"},{"issue":"1","key":"84_CR166","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1517\/17425247.1.1.99","volume":"1","author":"S Raghava","year":"2004","unstructured":"Raghava S, Hammond M, Kompella UB (2004) Periocular routes for retinal drug delivery. Expert Opin Drug Deliv 1(1):99\u2013114","journal-title":"Expert Opin Drug Deliv"},{"issue":"1","key":"84_CR167","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jconrel.2010.08.028","volume":"148","author":"VP Ranta","year":"2010","unstructured":"Ranta VP, Mannermaa E, Lummepuro K, Subrizi A, Laukkanen A, Antopolsky M et al (2010) Barrier analysis of periocular drug delivery to the posterior segment. J Control Release 148(1):42\u201348","journal-title":"J Control Release"},{"key":"84_CR168","doi-asserted-by":"crossref","unstructured":"Reimondez-Troitino S, Csaba N, Alonso MJ, de la Fuente M (2015) Nanotherapies for the treatment of ocular diseases. Eur J Pharm Biopharm 95(Pt B):279\u2013293","DOI":"10.1016\/j.ejpb.2015.02.019"},{"key":"84_CR169","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ejpb.2015.02.019","volume":"95","author":"S Reimondez-Troitino","year":"2015","unstructured":"Reimondez-Troitino S, Csaba N, Alonso MJ, de la Fuente M (2015b) Nanotherapies for the treatment of ocular diseases. Eur J Pharm Biopharm 95:279\u2013293","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"84_CR170","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ejpb.2011.11.017","volume":"80","author":"M Rodriguez-Aller","year":"2012","unstructured":"Rodriguez-Aller M, Kaufmann B, Guillarme D, Stella C, Furrer P, Rudaz S et al (2012) In vivo characterisation of a novel water-soluble cyclosporine A prodrug for the treatment of dry eye disease. Eur J Pharm Biopharm 80(3):544\u2013552","journal-title":"Eur J Pharm Biopharm"},{"issue":"4","key":"84_CR171","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1167\/iovs.13-13707","volume":"55","author":"CL Rowe-Rendleman","year":"2014","unstructured":"Rowe-Rendleman CL, Durazo SA, Kompella UB, Rittenhouse KD, Di Polo A, Weiner AL et al (2014) Drug and gene delivery to the back of the eye: from bench to bedside. Invest Ophthalmol Vis Sci 55(4):2714\u20132730","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"84_CR172","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ejpb.2015.02.032","volume":"96","author":"M Ruponen","year":"2015","unstructured":"Ruponen M, Urtti A (2015) Undefined role of mucus as a barrier in ocular drug delivery. Eur J Pharm Biopharm 96:442\u2013446","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"84_CR173","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3109\/02713680903521936","volume":"35","author":"S Saati","year":"2010","unstructured":"Saati S, Lo R, Li PY, Meng E, Varma R, Humayun MS (2010) Mini drug pump for ophthalmic use. Curr Eye Res 35(3):192\u2013201","journal-title":"Curr Eye Res"},{"issue":"1","key":"84_CR174","first-page":"35","volume":"49","author":"P Sachinkumar","year":"2015","unstructured":"Sachinkumar P, Atul K, Sandip B, Shitalkumar P (2015) Formuation and evaluation of an in situ gel for ocular drug delivery of anticonjunctival drug. Cellul Chem Technol 49(1):35\u201340","journal-title":"Cellul Chem Technol"},{"issue":"7","key":"84_CR175","first-page":"1221","volume":"39","author":"P Saha","year":"1998","unstructured":"Saha P, Yang JJ, Lee VH (1998) Existence of a p-glycoprotein drug efflux pump in cultured rabbit conjunctival epithelial cells. Invest Ophthalmol Vis Sci 39(7):1221\u20131226","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"84_CR176","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/archopht.1983.01040020616024","volume":"101","author":"DR Sanders","year":"1983","unstructured":"Sanders DR, Goldstick B, Kraff C, Hutchins R, Bernstein MS, Evans MA (1983) Aqueous penetration of oral and topical indomethacin in humans. Arch Ophthalmol 101(10):1614\u20131616","journal-title":"Arch Ophthalmol"},{"key":"84_CR177","unstructured":"Santipharp P, Laman LA (2008) Ophthalmic nanoparticulate formulation of a cyclooxygenase-2 selective inhibitor. Patent US20080145430 A1"},{"issue":"4","key":"84_CR178","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2165\/00003088-199018040-00001","volume":"18","author":"RD Schoenwald","year":"1990","unstructured":"Schoenwald RD (1990) Ocular drug delivery. Pharmacokinetic considerations. Clin Pharmacokinet 18(4):255\u2013269","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"84_CR179","first-page":"509","volume":"21","author":"J Sedlacek","year":"1965","unstructured":"Sedlacek J (1965) Possibility of the application of ophthalmic drugs with the use of gel contact lenses. Cesk Oftalmol 21(6):509\u2013512","journal-title":"Cesk Oftalmol"},{"issue":"3","key":"84_CR180","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/ddr.430060307","volume":"6","author":"JW Shell","year":"1985","unstructured":"Shell JW (1985) Ophthalmic drug delivery systems. Drug Dev Res 6(3):245\u2013261","journal-title":"Drug Dev Res"},{"issue":"3","key":"84_CR181","doi-asserted-by":"crossref","first-page":"E371","DOI":"10.1208\/aapsj0903044","volume":"9","author":"Y Shen","year":"2007","unstructured":"Shen Y, Tu J (2007) Preparation and ocular pharmacokinetics of ganciclovir liposomes. AAPS J 9(3):E371\u2013E377","journal-title":"AAPS J"},{"issue":"1\u20132","key":"84_CR182","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ijpharm.2010.10.008","volume":"402","author":"J Shen","year":"2010","unstructured":"Shen J, Deng Y, Jin X, Ping Q, Su Z, Li L (2010) Thiolated nanostructured lipid carriers as a potential ocular drug delivery system for cyclosporine A: improving in vivo ocular distribution. Int J Pharm 402(1\u20132):248\u2013253","journal-title":"Int J Pharm"},{"issue":"1-2","key":"84_CR183","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ijpharm.2011.03.041","volume":"412","author":"J Shen","year":"2011","unstructured":"Shen J, Gan L, Zhu C, Zhang X, Dong Y, Jiang M et al (2011) Novel NSAIDs ophthalmic formulation: flurbiprofen axetil emulsion with low irritancy and improved anti-inflammation effect. Int J Pharm 412(1-2):115\u2013122","journal-title":"Int J Pharm"},{"issue":"2","key":"84_CR184","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jconrel.2011.06.011","volume":"155","author":"A Shukla","year":"2011","unstructured":"Shukla A, Fuller RC, Hammond PT (2011) Design of multi-drug release coatings targeting infection and inflammation. J Control Release 155(2):159\u2013166","journal-title":"J Control Release"},{"issue":"1","key":"84_CR185","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijpharm.2013.05.040","volume":"453","author":"HH Sigurdsson","year":"2013","unstructured":"Sigurdsson HH, Kirch J, Lehr CM (2013) Mucus as a barrier to lipophilic drugs. Int J Pharm 453(1):56\u201364","journal-title":"Int J Pharm"},{"issue":"Suppl 1","key":"84_CR186","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/S0039-6257(02)00302-8","volume":"47","author":"B Sjoquist","year":"2002","unstructured":"Sjoquist B, Stjernschantz J (2002) Ocular and systemic pharmacokinetics of latanoprost in humans. Surv Ophthalmol 47(Suppl 1):S6\u2013S12","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"84_CR187","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ejmech.2009.10.017","volume":"45","author":"G Spataro","year":"2010","unstructured":"Spataro G, Malecaze F, Turrin CO, Soler V, Duhayon C, Elena PP et al (2010) Designing dendrimers for ocular drug delivery. Eur J Med Chem 45(1):326\u2013334","journal-title":"Eur J Med Chem"},{"issue":"Suppl 1","key":"84_CR188","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/S0039-6257(99)00086-7","volume":"44","author":"CW Spraul","year":"1999","unstructured":"Spraul CW, Lang GE, Grossniklaus HE, Lang GK (1999) Histologic and morphometric analysis of the choroid, Bruch\u2019s membrane, and retinal pigment epithelium in postmortem eyes with age-related macular degeneration and histologic examination of surgically excised choroidal neovascular membranes. Surv Ophthalmol 44(Suppl 1):S10\u2013S32","journal-title":"Surv Ophthalmol"},{"issue":"3","key":"84_CR189","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1167\/iovs.04-0925","volume":"46","author":"H Steuer","year":"2005","unstructured":"Steuer H, Jaworski A, Elger B, Kaussmann M, Keldenich J, Schneider H et al (2005) Functional characterization and comparison of the outer blood-retina barrier and the blood-brain barrier. Invest Ophthalmol Vis Sci 46(3):1047\u20131053","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"84_CR190","doi-asserted-by":"crossref","first-page":"995","DOI":"10.3109\/02713689509000007","volume":"4","author":"RE Stratford Jr","year":"1985","unstructured":"Stratford RE Jr, Lee VH (1985) Ocular aminopeptidase activity and distribution in the albino rabbit. Curr Eye Res 4(9):995\u2013999","journal-title":"Curr Eye Res"},{"issue":"1","key":"84_CR191","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0378-5173(99)00106-4","volume":"184","author":"M Sznitowska","year":"1999","unstructured":"Sznitowska M, Zurowska-Pryczkowska K, Janicki S, Jarvinen T (1999) Miotic effect and irritation potential of pilocarpine prodrug incorporated into a submicron emulsion vehicle. Int J Pharm 184(1):115\u2013120","journal-title":"Int J Pharm"},{"issue":"5","key":"84_CR192","first-page":"205","volume":"7","author":"M Taban","year":"2006","unstructured":"Taban M, Chen B, Perry JD (2006) Update on punctal plugs. Compr Ophthalmol Updat 7(5):205\u2013212, discussion 213\u2013214","journal-title":"Compr Ophthalmol Updat"},{"issue":"6","key":"84_CR193","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1080\/02713680600693629","volume":"31","author":"RS Talluri","year":"2006","unstructured":"Talluri RS, Katragadda S, Pal D, Mitra AK (2006) Mechanism of L-ascorbic acid uptake by rabbit corneal epithelial cells: evidence for the involvement of sodium-dependent vitamin C transporter 2. Curr Eye Res 31(6):481\u2013489","journal-title":"Curr Eye Res"},{"issue":"5-6","key":"84_CR194","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.drudis.2010.12.004","volume":"16","author":"TR Thrimawithana","year":"2011","unstructured":"Thrimawithana TR, Young S, Bunt CR, Green C, Alany RG (2011) Drug delivery to the posterior segment of the eye. Drug Discov Today 16(5-6):270\u2013277","journal-title":"Drug Discov Today"},{"issue":"4","key":"84_CR195","first-page":"555","volume":"11","author":"U Ticho","year":"1979","unstructured":"Ticho U, Blumenthal M, Zonis S, Gal A, Blank I, Mazor ZW (1979) A clinical trial with Piloplex--a new long-acting pilocarpine compound: preliminary report. Ann Ophthalmol 11(4):555\u2013561","journal-title":"Ann Ophthalmol"},{"issue":"6","key":"84_CR196","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1089\/108076802321021081","volume":"18","author":"GS Tirucherai","year":"2002","unstructured":"Tirucherai GS, Dias C, Mitra AK (2002) Corneal permeation of ganciclovir: mechanism of ganciclovir permeation enhancement by acyl ester prodrug design. J Ocul Pharmacol Ther 18(6):535\u2013548","journal-title":"J Ocul Pharmacol Ther"},{"issue":"11","key":"84_CR197","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/jgm.1093","volume":"9","author":"YC Tong","year":"2007","unstructured":"Tong YC, Chang SF, Liu CY, Kao WW, Huang CH, Liaw J (2007) Eye drop delivery of nano-polymeric micelle formulated genes with cornea-specific promoters. J Gene Med 9(11):956\u2013966","journal-title":"J Gene Med"},{"issue":"3","key":"84_CR198","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2217\/nnm.10.10","volume":"5","author":"R Trivedi","year":"2010","unstructured":"Trivedi R, Kompella UB (2010) Nanomicellar formulations for sustained drug delivery: strategies and underlying principles. Nanomedicine (Lond) 5(3):485\u2013505","journal-title":"Nanomedicine (Lond)"},{"issue":"50","key":"84_CR199","doi-asserted-by":"crossref","first-page":"505101","DOI":"10.1088\/0957-4484\/23\/50\/505101","volume":"23","author":"R Trivedi","year":"2012","unstructured":"Trivedi R, Redente EF, Thakur A, Riches DW, Kompella UB (2012) Local delivery of biodegradable pirfenidone nanoparticles ameliorates bleomycin-induced pulmonary fibrosis in mice. Nanotechnology 23(50):505101","journal-title":"Nanotechnology"},{"issue":"8","key":"84_CR200","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1021\/mp300716t","volume":"10","author":"P Tyagi","year":"2013","unstructured":"Tyagi P, Barros M, Stansbury JW, Kompella UB (2013) Light-activated, in situ forming gel for sustained suprachoroidal delivery of bevacizumab. Mol Pharm 10(8):2858\u20132867","journal-title":"Mol Pharm"},{"issue":"1-2","key":"84_CR201","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ijpharm.2012.05.033","volume":"434","author":"AD Vadlapudi","year":"2012","unstructured":"Vadlapudi AD, Vadlapatla RK, Kwatra D, Earla R, Samanta SK, Pal D et al (2012a) Targeted lipid based drug conjugates: a novel strategy for drug delivery. Int J Pharm 434(1-2):315\u2013324","journal-title":"Int J Pharm"},{"issue":"1","key":"84_CR202","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2174\/157489112799829765","volume":"7","author":"AD Vadlapudi","year":"2012","unstructured":"Vadlapudi AD, Vadlapatla RK, Mitra AK (2012b) Current and emerging antivirals for the treatment of cytomegalovirus (CMV) retinitis: an update on recent patents. Recent Pat Antiinfect Drug Discov 7(1):8\u201318","journal-title":"Recent Pat Antiinfect Drug Discov"},{"issue":"1","key":"84_CR203","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/jop.2013.0157","volume":"30","author":"AD Vadlapudi","year":"2014","unstructured":"Vadlapudi AD, Cholkar K, Vadlapatla RK, Mitra AK (2014) Aqueous nanomicellar formulation for topical delivery of biotinylated lipid prodrug of acyclovir: formulation development and ocular biocompatibility. J Ocul Pharmacol Ther 30(1):49\u201358","journal-title":"J Ocul Pharmacol Ther"},{"key":"84_CR204","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2174\/1874104500802010066","volume":"2","author":"R Valls","year":"2008","unstructured":"Valls R, Vega E, Garcia ML, Egea MA, Valls JO (2008) Transcorneal permeation in a corneal device of non-steroidal anti-inflammatory drugs in drug delivery systems. Open Med Chem J 2:66\u201371","journal-title":"Open Med Chem J"},{"issue":"1","key":"84_CR205","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jconrel.2004.09.015","volume":"102","author":"TF Vandamme","year":"2005","unstructured":"Vandamme TF, Brobeck L (2005) Poly(amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide. J Control Release 102(1):23\u201338","journal-title":"J Control Release"},{"issue":"11","key":"84_CR206","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1002\/jps.20685","volume":"95","author":"E Vega","year":"2006","unstructured":"Vega E, Egea MA, Valls O, Espina M, Garcia ML (2006) Flurbiprofen loaded biodegradable nanoparticles for ophthalmic administration. J Pharm Sci 95(11):2393\u20132405","journal-title":"J Pharm Sci"},{"issue":"1","key":"84_CR207","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1021\/bc034164r","volume":"15","author":"SV Vinogradov","year":"2004","unstructured":"Vinogradov SV, Batrakova EV, Kabanov AV (2004) Nanogels for oligonucleotide delivery to the brain. Bioconjug Chem 15(1):50\u201360","journal-title":"Bioconjug Chem"},{"issue":"11","key":"84_CR208","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1021\/mp300245r","volume":"9","author":"SK Vooturi","year":"2012","unstructured":"Vooturi SK, Kadam RS, Kompella UB (2012) Transporter targeted gatifloxacin prodrugs: synthesis, permeability, and topical ocular delivery. Mol Pharm 9(11):3136\u20133146","journal-title":"Mol Pharm"},{"issue":"4","key":"84_CR209","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3109\/10611860903450023","volume":"18","author":"S Wadhwa","year":"2010","unstructured":"Wadhwa S, Paliwal R, Paliwal SR, Vyas SP (2010) Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: development, characterization, and evaluation. J Drug Target 18(4):292\u2013302","journal-title":"J Drug Target"},{"key":"84_CR210","unstructured":"Wong VG (1989) Biodegradable ocular implants. Google Patents"},{"issue":"Pt 3","key":"84_CR211","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1113\/jphysiol.1996.sp021254","volume":"491","author":"J Wu","year":"1996","unstructured":"Wu J, Zhang JJ, Koppel H, Jacob TJ (1996) P-glycoprotein regulates a volume-activated chloride current in bovine non-pigmented ciliary epithelial cells. J Physiol 491(Pt 3):743\u2013755","journal-title":"J Physiol"},{"issue":"5","key":"84_CR212","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1124\/dmd.108.026286","volume":"37","author":"CD Xiang","year":"2009","unstructured":"Xiang CD, Batugo M, Gale DC, Zhang T, Ye J, Li C et al (2009) Characterization of human corneal epithelial cell model as a surrogate for corneal permeability assessment: metabolism and transport. Drug Metab Dispos 37(5):992\u2013998","journal-title":"Drug Metab Dispos"},{"key":"84_CR213","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijbiomac.2013.05.034","volume":"60","author":"X Xu","year":"2013","unstructured":"Xu X, Weng YH, Xu L, Chen H (2013) Sustained release of avastin (R) from polysaccharides cross-linked hydrogels for ocular drug delivery. Int J Biol Macromol 60:272\u2013276","journal-title":"Int J Biol Macromol"},{"issue":"11","key":"84_CR214","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1002\/jps.24588","volume":"104","author":"B Yavuz","year":"2015","unstructured":"Yavuz B, Pehlivan SB, Vural I, Unlu N (2015) In vitro\/in vivo evaluation of Dexamethasone--PAMAM dendrimer complexes for retinal drug delivery. J Pharm Sci 104(11):3814\u20133823","journal-title":"J Pharm Sci"},{"issue":"7","key":"84_CR215","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.drudis.2015.01.013","volume":"20","author":"VK Yellepeddi","year":"2015","unstructured":"Yellepeddi VK, Sheshala R, McMillan H, Gujral C, Jones D, Raghu Raj Singh T (2015) Punctal plug: a medical device to treat dry eye syndrome and for sustained drug delivery to the eye. Drug Discov Today 20(7):884\u2013889","journal-title":"Drug Discov Today"},{"issue":"3","key":"84_CR216","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.exer.2008.04.002","volume":"87","author":"I Yenice","year":"2008","unstructured":"Yenice I, Mocan MC, Palaska E, Bochot A, Bilensoy E, Vural I et al (2008) Hyaluronic acid coated poly-epsilon-caprolactone nanospheres deliver high concentrations of cyclosporine A into the cornea. Exp Eye Res 87(3):162\u2013167","journal-title":"Exp Eye Res"},{"issue":"1\u20132","key":"84_CR217","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ijpharm.2014.04.053","volume":"470","author":"J Yu","year":"2014","unstructured":"Yu J, Xu X, Yao FL, Luo ZC, Jin L, Xie BB et al (2014) In situ covalently cross-linked PEG hydrogel for ocular drug delivery applications. Int J Pharm 470(1\u20132):151\u2013157","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"84_CR218","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ijpharm.2007.07.045","volume":"349","author":"XB Yuan","year":"2008","unstructured":"Yuan XB, Yuan YB, Jiang W, Liu J, Tian EJ, Shun HM et al (2008) Preparation of rapamycin-loaded chitosan\/PLA nanoparticles for immunosuppression in corneal transplantation. Int J Pharm 349(1\u20132):241\u2013248","journal-title":"Int J Pharm"},{"issue":"7","key":"84_CR219","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1124\/dmd.108.021121","volume":"36","author":"T Zhang","year":"2008","unstructured":"Zhang T, Xiang CD, Gale D, Carreiro S, Wu EY, Zhang EY (2008) Drug transporter and cytochrome P450 mRNA expression in human ocular barriers: implications for ocular drug disposition. Drug Metab Dispos 36(7):1300\u20131307","journal-title":"Drug Metab Dispos"}],"container-title":["Handbook of Experimental Pharmacology","Pharmacologic Therapy of Ocular Disease"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2016_84","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T20:33:50Z","timestamp":1568493230000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/164_2016_84"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9783319582887","9783319582900"],"references-count":219,"URL":"https:\/\/doi.org\/10.1007\/164_2016_84","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}